John Niemi Jr.

Before devoting his work full-time to Armas Pharmaceuticals as President & CEO, John spent almost 37 years developing relationships, gaining experience and building a portfolio of skills in the pharmaceutical industry that will serve as the backbone of his successful leadership.

Much of Johns' early career was spent developing his knowledge of sales. During his time at Faulding Pharmaceuticals, where he served as Director of Sales for the East Coast, he oversaw U.S. East Coast Sales; GPO's; Wholesalers; and territory managers. He then moved on to Cura Pharmaceuticals where he served as the Vice President of Sales. John took advantage of this opportunity and developed a myriad of skills relating to pharmaceuticals sales including: developing sales plans, introducing product lines and successfully launching products, among others.

To further hone his knowledge of the pharmaceutical industry, John moved to Sagent Pharmaceuticals where he formed a strong foundation of knowledge in business development as the Senior Director of Business Development. Here John formed strong industry relationships and explored different avenues for business opportunities and strategies that ensured business growth. Additionally, John was responsible for bringing Glydo to Sagent where the product is sold today. He continued developing these skills during his tenure at Amneal Pharmaceuticals. John served as Vice President of Amneal Biosciences, LLC; where he was responsible for starting their injectable division. This position allowed John to develop international relationships along with offering him insights into product evaluation and company acquisitions.

John brings with him a well-rounded set of skills in both sales and business development, which combined, will help Armas Pharmaceuticals have an insight into partnerships and products that lead to strong revenue growth potential.